Heparin therapy reduces 28-day mortality in adult severe sepsis patients: a systematic review and meta-analysis (Q34423049)

2 August 2017

3 references

4 August 2019

18 November 2019

12 December 2020

0 references

Heparin therapy reduces 28-day mortality in adult severe sepsis patients: a systematic review and meta-analysis (English)

1 reference

2 August 2017

1 reference

12 December 2020

1 reference

4 August 2019

1 reference

18 November 2019

1 reference

12 December 2020

1 reference

1 reference

1

Changsong Wang

1 reference

2 August 2017

10

Enyou Li

1 reference

2 August 2017

2

Chunjie Chi

1 reference

2 August 2017

5

Libo Guo

1 reference

2 August 2017

Lei Guo

3

1 reference

2 August 2017

Xiaoyang Wang

4

1 reference

2 August 2017

Jiaxiao Sun

6

1 reference

2 August 2017

Bo Sun

7

1 reference

2 August 2017

Shanshan Liu

8

1 reference

2 August 2017

Xuenan Chang

9

1 reference

2 August 2017

16 October 2014

4 references

2 August 2017

4 August 2019

18 November 2019

12 December 2020

4 references

2 August 2017

4 August 2019

18 November 2019

12 December 2020

18

1 reference

2 August 2017

5

1 reference

2 August 2017

563

1 reference

Creative Commons Attribution

2 August 2017

3 references

4 August 2019

18 November 2019

12 December 2020

0 references

https://scigraph.springernature.com/pub.10.1186/s13054-014-0563-4

0 references

cites work

Low-dose heparin as treatment for early disseminated intravascular coagulation during sepsis: A prospective clinical study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4213495

Severe sepsis and septic shock

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4213495

Heparin thromboprophylaxis in medical-surgical critically ill patients: a systematic review and meta-analysis of randomized trials

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4213495

Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4213495

Efficacy and bleeding risk of antithrombin supplementation in septic disseminated intravascular coagulation: a prospective multicenter survey

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4213495

Dalteparin versus Unfractionated Heparin in Critically Ill Patients

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4213495

Corticosteroids in the prevention and treatment of acute respiratory distress syndrome (ARDS) in adults: meta-analysis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4213495

Antithrombin III in critically ill patients: systematic review with meta-analysis and trial sequential analysis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4213495

Dynamic evolution of coagulopathy in the first day of severe sepsis: relationship with mortality and organ failure

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4213495

Hazard ratio in clinical trials

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4213495

Measuring inconsistency in meta-analyses

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4213495

Science review: role of coagulation protease cascades in sepsis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4213495

Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4213495

Efficacy and safety of recombinant human activated protein C for severe sepsis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4213495

Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4213495

Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4213495

The hazards of scoring the quality of clinical trials for meta-analysis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4213495

Heparin in inflammation: potential therapeutic applications beyond anticoagulation.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4213495

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4213495

Incorporating variations in the quality of individual randomized trials into meta-analysis.

6 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2FS13054-014-0563-4

Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2FS13054-014-0563-4

Clinical study of low molecular weight heparin therapy for sepsis

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4213495

Anticoagulation in sepsis: Is low-dose heparin as effective as activated protein C?

27 October 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2FS13054-014-0563-4

Prophylactic heparin in patients with severe sepsis treated with drotrecogin alfa (activated)

21 January 2018

1 reference

12 December 2020

Unfractioned heparin for treatment of sepsis: A randomized clinical trial (The HETRASE Study)

1 reference

12 December 2020

The role of heparin and allied compounds in the treatment of sepsis

1 reference

12 December 2020

A new and rapid scoring system to assess the scientific evidence from clinical trials

1 reference

12 December 2020

[Anticoagulation and sepsis: the opportunity for a new use of heparin?]

1 reference

12 December 2020

[Therapeutic effects of early administration of low-dose heparin in patients with severe sepsis]

1 reference

12 December 2020

Clinical evaluation of new therapeutic concepts in septic shock

1 reference

12 December 2020

Disseminated intravascular coagulation in sepsis

1 reference

12 December 2020

Effect of recombinant activated protein C and low-dose heparin on neutrophil-endothelial cell interactions in septic shock

1 reference

12 December 2020

[The study of the mechanism of the effect of heparin on tissue perfusion of sepsis patients]

1 reference

12 December 2020

An empirical study of the possible relation of treatment differences to quality scores in controlled randomized clinical trials

1 reference

12 December 2020

[Evaluation of clinical effects on low-dose heparin therapy for sepsis]

1 reference

12 December 2020

10.1186/S13054-014-0563-4

Identifiers

DOI

1 reference

2 August 2017

1 reference

2 August 2017

1 reference